- The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative womenHeather Sevinsky
Research and Development, Bristol Myers Squibb, Princeton, NJ, USA
Antivir Ther 16:149-56. 2011..Women of childbearing age represent a growing proportion of people living with HIV. Preventing pregnancy is important in HIV-infected women receiving efavirenz as part of their antiretroviral therapy...
- Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE StudyLi Zhu
Bristol Myers Squibb, Research and Development, Princeton, NJ, USA
J Antimicrob Chemother 67:465-8. 2012..To characterize the pharmacokinetics and inhibitory quotient (IQ) of atazanavir/ritonavir- and lopinavir/ritonavir-based regimens in HIV-infected, treatment-naive patients...